New drug SEP-631 tested for safety in healthy people
Knowledge-focused
Completed
This early-phase trial tested the safety and tolerability of a new drug called SEP-631 in 120 healthy adults aged 18 to 60. Participants received either the drug or a placebo to check for side effects and how the drug moves through the body. Since this study was done in healthy v…
Phase: PHASE1 • Sponsor: Septerna, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC